iProgen Biotech out-licensed its intracellular protein delivery technology for enhanced delivery of antifreeze proteins to Lucy Biotech Ltd., based in the Hong Kong Science and Technology Park, Hong Kong (www.LucyBiotech.com). Lucy Biotech is developing next-generation cryopreservation technologies using antifreeze proteins for cells and tissues to help reduce the toxicity associated with traditional small-molecule cryoprotectants.
